trending Market Intelligence /marketintelligence/en/news-insights/trending/S5KlhYwjWFUdWHFf9AxwAQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

CorMedix appoints director

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


CorMedix appoints director

CorMedix Inc.'s board elected Gary Gelbfish as a director, effective Aug. 3, to serve until the 2018 annual meeting.

Gelbfish currently serves as CEO and chairman of Metrodora Therapeutics LLC, a clinical stage biotechnology company.